BeiGene (BGNE) Releases Earnings Results, Misses Expectations By $-0.05 EPS

BeiGene (BGNE) reported quarterly earnings results on Wednesday, Aug-10-2016. The company reported $-0.73 earnings per share for the quarter, missing the analyst consensus estimate by $-0.05. Analysts had a consensus of $-0.68. The company posted revenue of $.40 million in the period, compared to analysts expectations of $2.08 million. The company’s revenue was down -71.4% compared to the same quarter last year.

In a different news, on Feb 9, 2016, Howard Liang (CFO) purchased 65,000 shares at $1.85 per share price. According to the SEC, on Feb 9, 2016, Ruirong Yuan (Chief Medical Officer) purchased 130,000 shares at $1.85 per share price.


Leave a Reply

BeiGene - Is it time to Sell?

Top Brokerage Firms are advising their investors on BeiGene. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.